NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Prophylaxis of influenza infection
Date of first enrollment	25/03/2011
Target sample size	40
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : KD-FLU(trivalent inactivated influenza vaccine) INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : subcutaneous injection

Outcome(s)

Primary Outcome	Immunogenicity HI antibody titer against antigens
Secondary Outcome	Immunogenicity Neutralizing antibody titer against influenza viruses

Key inclusion & exclusion criteria

Age minimum	>=
Age maximum	<= 12age old
Gender	Both
Include criteria	Healthy childeren
Exclude criteria	Known history of influenza or received influenza vaccination within six months.